Inogen, Inc. (INGN)

USD 8.5

(-6.8%)

Market Cap (In USD)

202.45 Million

Revenue (In USD)

315.66 Million

Net Income (In USD)

-102.44 Million

Avg. Volume

199.73 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5.08-13.33
PE
-
EPS
-
Beta Value
1.045
ISIN
US45780L1044
CUSIP
45780L104
CIK
1294133
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Kevin R. M. Smith
Employee Count
-
Website
https://www.inogen.com
Ipo Date
2014-02-14
Details
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.